Submitted by Anonymous (not verified) on 8 September 2023 - 14:50
Human medicines European public assessment report (EPAR): Teriparatide Sun, teriparatide, Osteoporosis;Osteoporosis, Postmenopausal, Date of authorisation: 18/11/2022, Revision: 1, Status: Authorised
Source: